Logo

organ transplant

Verici Dx Aims to Predict Kidney Transplant Rejection Risk Using Gene Expression Profiles
Premium

The 2020 spinout from UK firm Renalytix is launching an acute rejection risk test, with two other transplant tests expected to launch within the next two years.

Omixon Picks up Option to Acquire Organ Monitoring Group

The option comes as part of an alliance between the companies to codevelop an organ transplant monitoring assay.

Oncocyte Q1 Revenues Rise 27 Percent on DetermaRx Activity

The Irvine, California-based diagnostics firm reported $1.4 million in revenue, missing the consensus Wall Street estimate of $2.2 million.

Hologic Nabs FDA Approval for Quantitative Cytomegalovirus Test

The test runs on Hologic's Panther system and is intended to be used for post-transplant pathogen detection and monitoring.

Natera Adds Clinical Utility Evidence for Cell-Free DNA in Allograft Health
Premium

Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure.

Apr 7, 2022

Post-Transplant Diabetes Risk Informed by Polygenic Risk Profiles in Donors, Recipients

Dec 13, 2021

CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients

Nov 24, 2021

NGeneBio Gets CE-IVD Mark for HLA Typing Assay

Nov 5, 2021

Natera Aiming to Translate Success in Colorectal Cancer Diagnostics Into Other Areas
Premium

Nov 5, 2021

Genome Diagnostics Makes €1M Investment in CRISPR Diagnostics Startup Scope Biosciences

Oct 29, 2021

CareDx Works Toward Goal of Becoming Essential Transplant Diagnostics Company
Premium

Sep 29, 2021

CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor

Jul 13, 2021

Natera Inks Distribution Deal With TomaLab for Italy

Apr 22, 2021

Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection

Mar 17, 2021

CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular

Feb 25, 2021

CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring
Premium

Feb 24, 2021

CareDx Q4 Revenues Up 64 Percent

Feb 11, 2021

Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples

Feb 8, 2021

Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test

Jan 27, 2021

Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
Premium

Jan 21, 2021

CareDx Prices $175M Common Stock Offering

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Jan 11, 2021

CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates

Jan 7, 2021

CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients

Nov 19, 2020

CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.